← Back to Search

Behavioural Intervention

Educational Tool for Stroke Prevention (BEAT STROKE Trial)

N/A
Waitlist Available
Research Sponsored by Lawson Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with ischemic stroke or TIA of any etiology
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months

Summary

This trial aims to test if using an educational tool can help improve following best practices for preventing secondary strokes caused by heart-related issues.

Who is the study for?
The WSO BEAT STROKE trial is for individuals who have had a stroke, specifically those with conditions like Patent Foramen Ovale or Atrial Fibrillation. It aims to see if following certain guidelines can prevent another stroke.
What is being tested?
This study tests an educational tool designed to help doctors stick to the best practices for preventing strokes that come from heart-related issues. Some participants will use this tool, while others won't, to compare outcomes.
What are the potential side effects?
Since this trial involves an educational and implementation tool rather than medication, traditional side effects are not expected. However, there may be indirect effects on patient care based on adherence to the guidelines.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a stroke or a transient ischemic attack.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Difference between the baseline and 6-month mean WSO BEAT Neurocardiology Score
Secondary study objectives
Difference between the baseline and 6-month mean WSO BEAT Neurocardiology Score for each of the 5 pre-specified cathegories.
Long-term achievement of the at 12 months.
Other study objectives
Exploratory endpoint. Major adverse cardiovascular events (MACE) at 12 months

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Intervention armActive Control1 Intervention
Sites randomized in this arm will receive the educational and implementation Neurocardiology tool with the aim of improving adherence to best practice recommendations for secondary stroke prevention of cardioembolic strokes, as defined by the WSO Systematic Review and Synthesis of Global Stroke Guidelines or more recent high-quality evidence published after the last stroke guidelines.
Group II: No interventionPlacebo Group1 Intervention
This group will not receive any of the educational and/or implementation Neurocardiology until the data collection is completed.

Find a Location

Who is running the clinical trial?

Lawson Health Research InstituteLead Sponsor
676 Previous Clinical Trials
414,243 Total Patients Enrolled
W.L.Gore & AssociatesIndustry Sponsor
99 Previous Clinical Trials
28,844 Total Patients Enrolled
MedtronicIndustry Sponsor
616 Previous Clinical Trials
761,481 Total Patients Enrolled
~1600 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top